Stay updated on COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib
Sign up to get notified when there's something new on the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page.

Latest updates to the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now reflects a software revision bump from v3.6.4 to v3.6.5, indicating an update to the underlying platform. This change represents a backend/version upgrade rather than a modification to study information shown on the page.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe history entry now shows Revision: v3.6.4 in place of v3.6.3. This updates the revision tag displayed for the study record on the history page.SummaryDifference0.0%

- Check51 days agoChange DetectedA new page revision (v3.6.3) is added to the history, replacing the previous revision (v3.6.2). This indicates a software/record update applied to the page.SummaryDifference0.0%

- Check58 days agoChange DetectedA new revision entry v3.6.2 was added to the page history, and the older v3.6.0 entry was removed. This represents a software update to the site without altering study content or data on the page.SummaryDifference0.0%

- Check72 days agoChange DetectedThe study's recruitment status was updated to No longer looking for participants, indicating recruitment has ceased. A new Revision: v3.6.0 entry has been added, replacing the previous Revision: v3.5.5.SummaryDifference0.2%

- Check80 days agoChange DetectedA new revision entry, v3.5.5, was added to the Study Record History, replacing the previous v3.5.4. This reflects an administrative update to the page rather than changes to the trial data.SummaryDifference0.0%

Stay in the know with updates to COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib
Enter your email address, and we'll notify you when there's something new on the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page.